Who owns Mablink Bioscience?

Mablink Bioscience is formerly owned by Sofinnova Partners, through Sofinnova Capital X, since 2022.

When did Sofinnova Partners acquire Mablink Bioscience?

Sofinnova Partners acquired Mablink Bioscience in 2022 and exited after 1 year.

Has Mablink Bioscience been sold?

Yes. Mablink Bioscience was exited in 2023 via Trade Sale.

Home/Companies/Biotech/Mablink Bioscience

Mablink Bioscience

Biotech·

France·Exited 2023·Held 1yr

Mablink Bioscience is a healthcare company, headquartered in France.

Entry

2022

Hold

1yr

Exit

2023

Est. EV

–

Most recent investor

Sofinnova Partners

3 ownership periods

Key facts

HQFrance

SectorHealthcare

French company developing next-generation antibody-drug conjugates using its hydrophilic drug-linker technology for cancer treatment. |…Read full notes

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

6 portfolio peers in Sofinnova Capital X

6 comparable biotech deals from other GPs

Exit details: type, year, MOIC (buyer on Pro)

Start free

Already a member?

Data refreshed weekly · Sourced from public filings